谷春雨-内页标题

皇家赌场网址_皇家赌场网址hj3737

谷春雨

谷春雨

副主任医师,讲师 / 无

挂 号 费:60元 (北京医保20元)


出诊日期:周四上午


专业专长:颅内肿瘤、颅底肿瘤、听神经瘤、垂体瘤、脑膜瘤等


团体简历

神经内科博士,留美博士后,副主任医师,1999于中国医科大学获临床医学学士学位;2003年于中国医科大学获神经内科硕士学位;同年于中国医科大学隶属盛京医院神经内科任务,2005年留学日本就读于日本浜松医科大学神经内科,2010年取得医学博士学位。同年留学美国俄亥俄州立大学医学院神经内科做博士后研讨任务。2012年返国,在都城医科大学三博脑科医院神经内科颅底肿瘤病区任务至今。临时从事神经条理脑肿瘤的临床和研讨任务,在脑肿瘤诊断、手术医治方面有丰厚的临床经历。

代表性文章

1.Liu H, Sun Q, Sun Y, Zhang J, Yuan H, Pang S, Qi X, Wang H, Zhang M, ZhangH, Yu C, Gu C:MELK and EZH2 Cooperate to Regulate Medulloblastoma CancerStem-like Cell Proliferation and Differentiation. Mol Cancer Res. 2017Sep;15(9):1275-1286

2. Zhang M, Wang Z, Zhang J, Zhang H, Gu C, Wang H, Yu C, Wu H:Metastases incerebellopontine angle from the tumors of central nerve system. J Clin Neurosci.2017 Aug;42:84-90

3. Kim SH, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, Nakano-Okuno M,Taylor D, Minata M, Sulman EP, Lee J, Bhat KP, Salcini AE, Nakano I: EZH2protects glioma stem cells from radiation-induced cell death in aMELK/FOXM1-dependent manner. Stem Cell Reports. 2015 Feb 10;4(2):226-38

4. Minata M, Gu C, Joshi K, Nakano-Okuno M, Hong C, Nguyen CH, Kornblum HI,Molla A, Nakano I: Multi-kinase inhibitor C1 triggers mitotic catastrophe ofglioma stem cells mainly through MELK kinase inhibition. PLoS One. 2014 Apr16;9(4):e92546

5. Gu C, Banasavadi-Siddegowda YK, Joshi K, Nakamura Y, Kurt H, Gupta S,Nakano I: Tumor-Specific Activation of the C-JUN/MELK Pathway Regulates GliomaStem Cell Growth in a p53-Dependent Manner. Stem Cell. 2013 May;31(5):870-81

6. Li S, Gu C, Gao Y, Amano S, Koizumi S, Tokuyama T, Namba H: Bystandereffect in glioma suicide gene therapy using bone marrow stromal cells. Stem CellRes. 2012 Nov;9(3):270-6

7. Gu C, Yokota N, Gao Y, Amano S, Koizumi S, Tokuyama T, Namba H: Targetingtherapy against promyelocytic leukemia gene using arsenic acids in experimentalintracranial medulloblastoma. Neurologia medico-chirurgica, 2012;52(2):62-7

8. Amano S, Gu C, Koizumi S, Tokuyama T, Namba H: Tumoricidal bystandereffect in the suicide gene therapy using mesenchymal stem cells does not injurenormal brain tissues. Cancer Lett. 2011 Jul 1;306(1):99-105

9. Amano S, Gu C, Koizumi S, Tokuyama T, Namba H:Timing of gancicloviradministration in glioma gene therapy using HSVtk gene-transduced mesenchymalstem cells. Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):245-50

10. Koizumi S, Gu C, Amano S, Yamamoto S, Ihara H, Tokuyama T, NambaH:Migration of mouse-induced pluripotent stem cells to glioma-conditioned mediumis mediated by tumor-associated specific growth factors. Oncol Lett. 2011Mar;2(2):283-288

11. Gu C, Yokota N, Gao Y, Yamamoto J, Tokuyama T, Namba H: Gene expressionof growth signaling pathways is up-regulated in CD133-positive medulloblastomacells. Oncol Lett. 2011 Mar;2(2):357-361

12. Gao Y, Gu C, Li S, Tokuyama T, Yokota N, Nakayama KI, Kitagawa M, NambaH:p27 modulates tropism of mesenchymal stem cells toward brain tumors. Exp TherMed. 2010 Jul;1(4):695-699

13. Gu C, Li S, Tokuyama T, Yokota N, Namba H: Therapeutic effect ofgenetically engineered mesenchymal stem cells in rat experimental leptomeningealglioma model. Cancer Lett. 291: 256–262, 2010

14. Amano S, Li S, Gu C, Gao Y, Koizumi S, Yamamoto S, Terakawa S, Namba H:Tumoricidal bystander effect-mediated suicide gene therapy of glioma usinggenetically engineered bone marrow-drived mesenchymal stem cells. Int J Oncol.35: 1265-1270, 2009


都城医科大学三博脑科医院 请您绿色出行

征询预定德律风:400-0655-120

所在:北京市海淀区香山一棵松50号

邮编:100093

Baidu
sogou